Esther Rajavelu, Officer of Spero Therapeutics SPRO, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $406.8K. The latest trade was on 05/04.

ER

ER

Esther Rajavelu

SEE REMARKS

Company

Spero Therapeutics SPRO

First filing

23/02/13

Trades

16 trades

Buys / sales

0 / 8

12-month net buying

−$406.8K

Last trade

05/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Spero TherapeuticsSPRO	Open-market sale	05/04	05/06	25,240 sh	$2.51	$63,352.4	−2.5%
Spero TherapeuticsSPRO	Open-market sale	02/06	02/09	87,917 sh2 trades	$2.36avg.	$207,484.12	−8.0%
Spero TherapeuticsSPRO	Open-market sale	02/02	02/04	18,442 sh	$2.20	$40,572.4	−1.6%
Spero TherapeuticsSPRO	Open-market sale	25/11/07	25/11/12	40,270 sh	$2.37	$95,439.9	−4.4%
Spero TherapeuticsSPRO	Open-market sale	25/02/05	25/02/05	20,689 sh	$0.78	$16,137.42	−2.8%
Spero TherapeuticsSPRO	Open-market sale	24/11/07–24/11/08	24/11/12	40,596 sh2 trades	$1.31avg.	$53,008.31	−9.7%